+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anticoagulant"

Thrombosis Drugs - Global Strategic Business Report - Product Thumbnail Image

Thrombosis Drugs - Global Strategic Business Report

  • Report
  • March 2025
  • 387 Pages
  • Global
From
From
Hemorrhagic Stroke Drugs - Global Strategic Business Report - Product Thumbnail Image

Hemorrhagic Stroke Drugs - Global Strategic Business Report

  • Report
  • March 2025
  • 287 Pages
  • Global
From
Atherosclerosis Drugs - Global Strategic Business Report - Product Thumbnail Image

Atherosclerosis Drugs - Global Strategic Business Report

  • Report
  • March 2025
  • 389 Pages
  • Global
From
Cardiomyopathy Therapies - Global Strategic Business Report - Product Thumbnail Image

Cardiomyopathy Therapies - Global Strategic Business Report

  • Report
  • March 2025
  • 250 Pages
  • Global
From
Heparin - Global Strategic Business Report - Product Thumbnail Image

Heparin - Global Strategic Business Report

  • Report
  • March 2025
  • 184 Pages
  • Global
From
From
Fondaparinux - Global Strategic Business Report - Product Thumbnail Image

Fondaparinux - Global Strategic Business Report

  • Report
  • March 2025
  • 93 Pages
  • Global
From
Cardiovascular Drugs - Global Strategic Business Report - Product Thumbnail Image

Cardiovascular Drugs - Global Strategic Business Report

  • Report
  • March 2025
  • 413 Pages
  • Global
From
Acute Coronary Syndrome - Global Strategic Business Report - Product Thumbnail Image

Acute Coronary Syndrome - Global Strategic Business Report

  • Report
  • February 2025
  • 182 Pages
  • Global
From
From
Chronic Venous Occlusions Treatment Market Report 2025 - Product Thumbnail Image

Chronic Venous Occlusions Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Hypertrophic Cardiomyopathy Treatment Market Report 2025 - Product Thumbnail Image

Hypertrophic Cardiomyopathy Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Ischemic Heart Disease (IHD) Drugs Market Report 2025 - Product Thumbnail Image

Ischemic Heart Disease (IHD) Drugs Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Venous Thromboembolism Market Report 2025 - Product Thumbnail Image

Venous Thromboembolism Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Atherosclerosis Drugs Market Report 2025 - Product Thumbnail Image

Atherosclerosis Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Myocardial Infarction Market Report 2025 - Product Thumbnail Image

Myocardial Infarction Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Acute Ischemic Stroke Drugs Market Report 2025 - Product Thumbnail Image

Acute Ischemic Stroke Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Report 2025 - Product Thumbnail Image

Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Critical Limb Ischemia Market Report 2025 - Product Thumbnail Image

Critical Limb Ischemia Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Loading Indicator

The anticoagulant market within the context of cardiovascular drugs is a rapidly growing sector of the pharmaceutical industry. Anticoagulants are drugs used to prevent the formation of blood clots, which can lead to serious medical conditions such as stroke and heart attack. These drugs are used to reduce the risk of thrombosis, a condition in which a blood clot forms in a blood vessel, blocking the flow of blood. Anticoagulants are also used to treat existing blood clots, as well as to prevent the formation of new ones. The anticoagulant market is driven by the increasing prevalence of cardiovascular diseases, such as coronary artery disease, stroke, and peripheral artery disease. The rising demand for anticoagulants is also driven by the increasing aging population, as well as the increasing awareness of the importance of preventive healthcare. Some of the major companies in the anticoagulant market include Bayer AG, Bristol-Myers Squibb, Pfizer, Sanofi, and Johnson & Johnson. These companies are engaged in the development, manufacture, and marketing of anticoagulant drugs. Show Less Read more